Delivery Order SPE2DB22D3011-SPE2DB24FQ3GL

Award Date 8/19/24
Potential Completion Date 9/10/24
Potential Value $2.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of PRAXBIND 5G DOSE (2X 2.5G/50ML) 50ML, a pharmaceutical product. The contract is a delivery order with a firm fixed price of $2,881.90 and an ultimate completion date of August 7, 2024. AmerisourceBergen, a major pharmaceutical distributor, will be delivering this product to support the medical needs of the U.S. government. The contract is not designated as a...
This federal contract award is for the delivery of PRAXBIND 5G DOSE (2X 2.5G/50ML) 50ML pharmaceutical products to the Defense Logistics Agency (DLA). The contract, valued at $4,037.49, is a delivery order issued under an Indefinite Delivery Contract (IDC) held by the prime contractor, AmerisourceBergen Drug Corp, Corporate Office Division. The IDC was awarded by the DLA Troop Support Medical, with a potential value up to $999,999,999 through December 2025, to provide a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense, to AmerisourceBergen Drug Corp. The $171,197.28 fixed-price delivery order contract is for the supply of pharmaceutical and medical products, including prescription medications, medical devices, and healthcare-related supplies. The contract is not set-aside and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) vehicle between AmerisourceBergen and...
This federal contract award, valued at $4,138.61, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order (DO) under the DLA's Indefinite Delivery Contract (IDC) with Amerisourcebergen, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to...
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $2,503.74, is a delivery order for pharmaceutical products and supplies to support the DLA's medical programs. The contract has an ultimate completion date of August 27, 2024 and is a firm fixed-price contract. There is no set-aside designation for this award. Amerisourcebergen is the prime...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution company. The $8,443.80 Firm Fixed Price delivery order contract is for the supply of various pharmaceutical products and medical supplies to support the Medical Supply Chain program within the Department of Defense. The contract has an ultimate completion date of August 19, 2024. AmerisourceBergen, the prime contractor, has been awarded multiple...
This federal contract award is for the delivery of pharmaceutical products and medical supplies to the U.S. government. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $2,354.76, was awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA), a component of the Department of Defense (DoD). The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The contract is a Delivery Order with a Firm Fixed Price pricing type, with a Ceiling Value of $2,784.18 and an Ultimate Completion Date of May 30, 2025. The contract is not set-aside and is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
This federal contract award, valued at $5,584.76, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for AmerisourceBergen to provide a comprehensive range of pharmaceutical products and...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,038.80 firm fixed-price delivery order is for pharmaceutical products and medical supplies, with a performance period extending through May 2025. The contract is not set aside and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA to provide global...
  • SPE2DB22D3011
    Indefinite Delivery Contract
  • SPE2DB22D3011-SPE2DB24FQ3GL
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of PRAXBIND 5G DOSE (2X 2.5G/50ML) 50ML, a pharmaceutical product. The contract is a firm fixed-price Delivery Order with a ceiling value of $2,881.90 and an ultimate completion date of September 10, 2024. This award is not designated as a set-aside contract. AmerisourceBergen, through its Corporate Office division, will be responsible for delivering the requested pharmaceutical product to support the DLA's medical supply requirements. The DLA is a defense agency that provides logistics, acquisition, and technical services to the U.S. military and other federal agencies. This contract award is part of the DLA's broader efforts to ensure the availability of critical medical commodities, including specialty medications, for military treatment facilities and other federal healthcare providers.

Generated 11/18/24, 9:29 AM